New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Access the report

›ETF Issuers›Invesco›PTH

PTH

Invesco DWA Healthcare Momentum ETF

Passive ETF Equity

The PTH Exchange Traded Fund (ETF) is provided by Invesco. It is built to track an index: Dorsey Wright Healthcare Technical Leaders Index. The PTH ETF provides physical exposure, so by buying it you actually own parts of all the 54 underlying holdings. This share class generates a stream of income by distributing dividends.

$59.92

+$2.5 (+4.31%) yesterday

2:30 PM 11/09/26 Closed

1D price range

$58.06$60.17

52W price range

$46.09$64.10

YTD Perf.

+15.53%

YTD Flows

Annualized volatility

Fund AuM

€253M

Share class AuM

€253M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

US46137V8524

TER

0.72%

Inception date

10/12/2006

Issuer

Invesco

Benchmark

Dorsey Wright Healthcare Technical Leaders Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
TDNA T. Rowe Price Biotech ETF	-4.96%
XBI State Street SPDR S&P Biotech ETF	-2.36%
CURE Global X S&P Biotech ETF	-0.06%
BBP Virtus LifeSci Biotech Products ETF	-1.69%
ARKG ARK Genomic Revolution ETF	-11.62%
XHE State Street SPDR S&P Health Care Equipment ETF	+2.85%
AAKG ARK Genomic Revolution UCITS ETF	-11.67%
XPH State Street SPDR S&P Pharmaceuticals ETF	+0.26%
FMED Fidelity Disruptive Medicine ETF	-2.55%
EKG First Trust Nasdaq Lux Digital Health Solutions ETF	-6.98%
XHS State Street SPDR S&P Health Care Services ETF	+1.01%
HELX Franklin Genomic Advancements ETF	-6.82%
PSCH Invesco S&P SmallCap Health Care ETF	+0.08%
SBIO ALPS Medical Breakthroughs ETF	+1.62%
WDNA WisdomTree BioRevolution UCITS ETF	-4.26%

API

PerformanceDec 31, 2025 - Nov 6, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 09/30/26

Healthcare

99.23%

Other

0.77%

Latest PTH news

No content available for this fund

FAQ about PTH

PTH is a passively managed ETF that invests in the US Health Care segment.

PTH tracks the Dorsey Wright Healthcare Technical Leaders Total Return Index - USD, through a full replication replication method.

PTH carries a total expense ratio (TER) of 0.72%.

PTH was introduced to the market on October 12, 2006.

Invesco DWA Healthcare Momentum ETF, PTH, is provided by Invesco. Learn more about Invesco here.

PTH oversees €253M in assets as of November 6, 2026.

PTH follows a distributing dividend policy, meaning it pays out income to investors. As of November 6, 2026, its 12-month trailing yield was 2.66%.

As of September 30, 2026, PTH has significant geographic allocations in USA, United Kingdom and Ireland.

As of September 30, 2026, PTH focuses largely on Healthcare.

As of September 30, 2026, PTH holds 54 positions in its portfolio, with 51.15% of assets concentrated in its top 15 holdings.

As of September 30, 2026, PTH top three holdings include Moderna, Inc., Guardant Health, Inc. and Roivant Sciences Ltd..

The base currency of PTH is USD.

Top 10 holdings

Data as of 09/30/26

Moderna, Inc.

6.40%

Guardant Health, Inc.

5.11%

Roivant Sciences Ltd.

5.06%

Revolution Medicines, Inc.

4.98%

10X Genomics, Inc.

3.99%

BrightSpring Health Services, Inc.

3.58%

Axsome Therapeutics, Inc.

3.44%

Twist Bioscience Corp.

2.92%

Illumina, Inc.

2.59%

Liquidia Corp.

2.47%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

Trackinsight Global ETF Survey 2026: ETFs' Next Act: From Access to Selection. Access the report

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

Invesco DWA Healthcare Momentum ETF

FAQ about PTH

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US